schliessen

Filtern

 

Bibliotheken

Cover Image

Breast cancer and hormone-replacement therapy in the Million Women Study

Current use of hormone-replacement therapy (HRT) increases the incidence of breast cancer. The Million Women Study was set up to investigate the effects of specific types of HRT on incident and fatal breast cancer. 1084110 UK women aged 50–64 years were recruited into the Million Women Study between... Full description

Journal Title: The Lancet (British edition) 2003, Vol.362 (9382), p.419-427
Main Author: Beral, Valerie
Format: Electronic Article Electronic Article
Language: English
Subjects:
Adverse and side effects
Age
Breast cancer
Breast Neoplasms - chemically induced
Breast Neoplasms - epidemiology
Breast Neoplasms - mortality
Cancer
England - epidemiology
Epidemiology
Estrogen
Estrogen Replacement Therapy - adverse effects
Estrogens
Fatalities
Female
Follow-Up Studies
Formulations
Health risk assessment
Health risks
Hormone replacement therapy
Hormone therapy
Humans
Incidence
Invasiveness
Mammography
Mass Screening - statistics & numerical data
Medical research
Menopause
Menstruation
Middle Aged
Mortality
National Health Programs - statistics & numerical data
Oncology, Experimental
Registries - statistics & numerical data
Risk
Risk assessment
Risk factors
Skin cancer
Statistics
Therapy
Tibolone
United Kingdom
Usage
Women
Womens health
Quelle: Alma/SFX Local Collection
Publisher: England: Elsevier Ltd
ID: ISSN: 0140-6736
Link: https://www.ncbi.nlm.nih.gov/pubmed/12927427
Zum Text:
SendSend as email Add to Book BagAdd to Book Bag
Staff View
recordid: cdi_proquest_miscellaneous_764188297
title: Breast cancer and hormone-replacement therapy in the Million Women Study
format: Article
creator:
  • Beral, Valerie
subjects:
  • Adverse and side effects
  • Age
  • Breast cancer
  • Breast Neoplasms - chemically induced
  • Breast Neoplasms - epidemiology
  • Breast Neoplasms - mortality
  • Cancer
  • England - epidemiology
  • Epidemiology
  • Estrogen
  • Estrogen Replacement Therapy - adverse effects
  • Estrogens
  • Fatalities
  • Female
  • Follow-Up Studies
  • Formulations
  • Health risk assessment
  • Health risks
  • Hormone replacement therapy
  • Hormone therapy
  • Humans
  • Incidence
  • Invasiveness
  • Mammography
  • Mass Screening - statistics & numerical data
  • Medical research
  • Menopause
  • Menstruation
  • Middle Aged
  • Mortality
  • National Health Programs - statistics & numerical data
  • Oncology, Experimental
  • Registries - statistics & numerical data
  • Risk
  • Risk assessment
  • Risk factors
  • Skin cancer
  • Statistics
  • Therapy
  • Tibolone
  • United Kingdom
  • Usage
  • Women
  • Womens health
ispartof: The Lancet (British edition), 2003, Vol.362 (9382), p.419-427
description: Current use of hormone-replacement therapy (HRT) increases the incidence of breast cancer. The Million Women Study was set up to investigate the effects of specific types of HRT on incident and fatal breast cancer. 1084110 UK women aged 50–64 years were recruited into the Million Women Study between 1996 and 2001, provided information about their use of HRT and other personal details, and were followed up for cancer incidence and death. Half the women had used HRT; 9364 incident invasive breast cancers and 637 breast cancer deaths were registered after an average of 2·6 and 4·1 years of follow-up, respectively. Current users of HRT at recruitment were more likely than never users to develop breast cancer (adjusted relative risk 1·66 [95% CI 1·58–1·75], p
language: eng
source: Alma/SFX Local Collection
identifier: ISSN: 0140-6736
fulltext: fulltext
issn:
  • 0140-6736
  • 1474-547X
url: Link


@attributes
NO1
SEARCH_ENGINEprimo_central_multiple_fe
SEARCH_ENGINE_TYPEPrimo Central Search Engine
RANK2.6509905
LOCALfalse
PrimoNMBib
record
control
sourceidgale_proqu
recordidTN_cdi_proquest_miscellaneous_764188297
sourceformatXML
sourcesystemPC
galeidA195445370
sourcerecordidA195445370
originalsourceidFETCH-LOGICAL-c700t-2be23f9af3663e8a56f7aece014f8a5f9e214e68d21f21cc2f3304f310127c013
addsrcrecordideNqNkl1vFCEUhidGY9fqT9BM9EJNnMrXwBAvTG3UmtR4UY3eEZY57NLMDCswJvvvZbobu23UbUjgAM95OcBbFI8xOsII89fnCDNUcUH5C0Rf5pjXFblTzDATrKqZ-HG3mP1BDooHMV4ghBhH9f3iABNJBCNiVpy-C6BjKo0eDIRSD2259KH3A1QBVp020MOQyrSEoFfr0g1TWH52Xef8UH73ebc8T2O7fljcs7qL8Gg7HhbfPrz_enJanX35-Onk-KwyAqFUkTkQaqW2lHMKja65FRoM5FJtnlkJBDPgTUuwJdgYYilFzNJ8ZyIMwvSweL7RXQX_c4SYVO-iga7TA_gxKsEZbhoiRSaf3SAv_BiGXJwiiEtJOBdNpp7-i8JSIkQRJVdSC92BcoP1KWgzHayOa8aFzNWh_1JY1ozVVOyhEGeSNo3M1NFfqNxa6J3J32NdXr8me7uEnRNe7STMx-gGiLmLbrFMcaHHGK_r3wbfUa83uAk-xgBWrYLrdVgrjNRkYHVpYDW5UyGqLg2sppd-sv2Ocd5De5W1dWwG3twQNi7plN2Y7-u6vfJvN9mQLfrLQVDROMjWb10Ak1Tr3R6F3wzKCvc
sourcetypeAggregation Database
isCDItrue
recordtypearticle
pqid199003032
display
typearticle
titleBreast cancer and hormone-replacement therapy in the Million Women Study
sourceAlma/SFX Local Collection
creatorBeral, Valerie
creatorcontribBeral, Valerie ; Million Women Study Collaborators
description
identifier
0ISSN: 0140-6736
1EISSN: 1474-547X
2DOI: 10.1016/S0140-6736(03)14065-2
3PMID: 12927427
4CODEN: LANCAO
languageeng
publisherEngland: Elsevier Ltd
subjectAdverse and side effects ; Age ; Breast cancer ; Breast Neoplasms - chemically induced ; Breast Neoplasms - epidemiology ; Breast Neoplasms - mortality ; Cancer ; England - epidemiology ; Epidemiology ; Estrogen ; Estrogen Replacement Therapy - adverse effects ; Estrogens ; Fatalities ; Female ; Follow-Up Studies ; Formulations ; Health risk assessment ; Health risks ; Hormone replacement therapy ; Hormone therapy ; Humans ; Incidence ; Invasiveness ; Mammography ; Mass Screening - statistics & numerical data ; Medical research ; Menopause ; Menstruation ; Middle Aged ; Mortality ; National Health Programs - statistics & numerical data ; Oncology, Experimental ; Registries - statistics & numerical data ; Risk ; Risk assessment ; Risk factors ; Skin cancer ; Statistics ; Therapy ; Tibolone ; United Kingdom ; Usage ; Women ; Womens health
ispartofThe Lancet (British edition), 2003, Vol.362 (9382), p.419-427
rights
02003 Elsevier Ltd
1COPYRIGHT 2003 Elsevier B.V.
2Copyright Lancet Ltd. Aug 9, 2003
3Copyright Elsevier Limited Aug 9, 2003
lds50peer_reviewed
oafree_for_read
citedbyFETCH-LOGICAL-c700t-2be23f9af3663e8a56f7aece014f8a5f9e214e68d21f21cc2f3304f310127c013
citesFETCH-LOGICAL-c700t-2be23f9af3663e8a56f7aece014f8a5f9e214e68d21f21cc2f3304f310127c013
links
openurl$$Topenurl_article
openurlfulltext$$Topenurlfull_article
thumbnail$$Usyndetics_thumb_exl
backlink$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/12927427$$D View this record in MEDLINE/PubMed
search
creatorcontrib
0Beral, Valerie
1Million Women Study Collaborators
title
0Breast cancer and hormone-replacement therapy in the Million Women Study
1The Lancet (British edition)
addtitleLancet
description
subject
0Adverse and side effects
1Age
2Breast cancer
3Breast Neoplasms - chemically induced
4Breast Neoplasms - epidemiology
5Breast Neoplasms - mortality
6Cancer
7England - epidemiology
8Epidemiology
9Estrogen
10Estrogen Replacement Therapy - adverse effects
11Estrogens
12Fatalities
13Female
14Follow-Up Studies
15Formulations
16Health risk assessment
17Health risks
18Hormone replacement therapy
19Hormone therapy
20Humans
21Incidence
22Invasiveness
23Mammography
24Mass Screening - statistics & numerical data
25Medical research
26Menopause
27Menstruation
28Middle Aged
29Mortality
30National Health Programs - statistics & numerical data
31Oncology, Experimental
32Registries - statistics & numerical data
33Risk
34Risk assessment
35Risk factors
36Skin cancer
37Statistics
38Therapy
39Tibolone
40United Kingdom
41Usage
42Women
43Womens health
issn
00140-6736
11474-547X
fulltexttrue
rsrctypearticle
creationdate2003
recordtypearticle
recordideNqNkl1vFCEUhidGY9fqT9BM9EJNnMrXwBAvTG3UmtR4UY3eEZY57NLMDCswJvvvZbobu23UbUjgAM95OcBbFI8xOsII89fnCDNUcUH5C0Rf5pjXFblTzDATrKqZ-HG3mP1BDooHMV4ghBhH9f3iABNJBCNiVpy-C6BjKo0eDIRSD2259KH3A1QBVp020MOQyrSEoFfr0g1TWH52Xef8UH73ebc8T2O7fljcs7qL8Gg7HhbfPrz_enJanX35-Onk-KwyAqFUkTkQaqW2lHMKja65FRoM5FJtnlkJBDPgTUuwJdgYYilFzNJ8ZyIMwvSweL7RXQX_c4SYVO-iga7TA_gxKsEZbhoiRSaf3SAv_BiGXJwiiEtJOBdNpp7-i8JSIkQRJVdSC92BcoP1KWgzHayOa8aFzNWh_1JY1ozVVOyhEGeSNo3M1NFfqNxa6J3J32NdXr8me7uEnRNe7STMx-gGiLmLbrFMcaHHGK_r3wbfUa83uAk-xgBWrYLrdVgrjNRkYHVpYDW5UyGqLg2sppd-sv2Ocd5De5W1dWwG3twQNi7plN2Y7-u6vfJvN9mQLfrLQVDROMjWb10Ak1Tr3R6F3wzKCvc
startdate20030809
enddate20030809
creatorBeral, Valerie
general
0Elsevier Ltd
1Elsevier B.V
2Elsevier Limited
scope
0CGR
1CUY
2CVF
3ECM
4EIF
5NPM
6AAYXX
7CITATION
8BSHEE
90TT
100TZ
110U~
123V.
137QL
147QP
157RV
167TK
177U7
187U9
197X7
207XB
2188A
2288C
2388E
2488G
2588I
268AF
278AO
288C1
298C2
308FE
318FH
328FI
338FJ
348FK
358G5
36ABUWG
37AN0
38ASE
39AZQEC
40BBNVY
41BEC
42BENPR
43BHPHI
44C1K
45DWQXO
46FPQ
47FYUFA
48GHDGH
49GNUQQ
50GUQSH
51H94
52HCIFZ
53K6X
54K9-
55K9.
56KB0
57KB~
58LK8
59M0R
60M0S
61M0T
62M1P
63M2M
64M2O
65M2P
66M7N
67M7P
68MBDVC
69NAPCQ
70PQEST
71PQQKQ
72PQUKI
73Q9U
74S0X
sort
creationdate20030809
titleBreast cancer and hormone-replacement therapy in the Million Women Study
authorBeral, Valerie
facets
frbrtype5
frbrgroupidcdi_FETCH-LOGICAL-c700t-2be23f9af3663e8a56f7aece014f8a5f9e214e68d21f21cc2f3304f310127c013
rsrctypearticles
prefilterarticles
languageeng
creationdate2003
topic
0Adverse and side effects
1Age
2Breast cancer
3Breast Neoplasms - chemically induced
4Breast Neoplasms - epidemiology
5Breast Neoplasms - mortality
6Cancer
7England - epidemiology
8Epidemiology
9Estrogen
10Estrogen Replacement Therapy - adverse effects
11Estrogens
12Fatalities
13Female
14Follow-Up Studies
15Formulations
16Health risk assessment
17Health risks
18Hormone replacement therapy
19Hormone therapy
20Humans
21Incidence
22Invasiveness
23Mammography
24Mass Screening - statistics & numerical data
25Medical research
26Menopause
27Menstruation
28Middle Aged
29Mortality
30National Health Programs - statistics & numerical data
31Oncology, Experimental
32Registries - statistics & numerical data
33Risk
34Risk assessment
35Risk factors
36Skin cancer
37Statistics
38Therapy
39Tibolone
40United Kingdom
41Usage
42Women
43Womens health
toplevel
0peer_reviewed
1online_resources
creatorcontrib
0Beral, Valerie
1Million Women Study Collaborators
collection
0Medline
1MEDLINE
2MEDLINE (Ovid)
3MEDLINE
4MEDLINE
5PubMed
6CrossRef
7Academic OneFile (A&I only)
8News PRO
9Pharma and Biotech Premium PRO
10Global News & ABI/Inform Professional
11ProQuest Central (Corporate)
12Bacteriology Abstracts (Microbiology B)
13Calcium & Calcified Tissue Abstracts
14Nursing & Allied Health Database
15Neurosciences Abstracts
16Toxicology Abstracts
17Virology and AIDS Abstracts
18Health & Medical Collection
19ProQuest Central (purchase pre-March 2016)
20Biology Database (Alumni Edition)
21Healthcare Administration Database (Alumni)
22Medical Database (Alumni Edition)
23Psychology Database (Alumni)
24Science Database (Alumni Edition)
25STEM Database
26ProQuest Pharma Collection
27Public Health Database
28Lancet Titles
29ProQuest SciTech Collection
30ProQuest Natural Science Collection
31Hospital Premium Collection
32Hospital Premium Collection (Alumni Edition)
33ProQuest Central (Alumni) (purchase pre-March 2016)
34Research Library (Alumni Edition)
35ProQuest Central (Alumni Edition)
36British Nursing Database
37British Nursing Index
38ProQuest Central Essentials
39Biological Science Collection
40eLibrary
41ProQuest Central
42Natural Science Collection
43Environmental Sciences and Pollution Management
44ProQuest Central Korea
45British Nursing Index (BNI) (1985 to Present)
46Health Research Premium Collection
47Health Research Premium Collection (Alumni)
48ProQuest Central Student
49Research Library Prep
50AIDS and Cancer Research Abstracts
51SciTech Premium Collection
52British Nursing Index
53Consumer Health Database (Alumni Edition)
54ProQuest Health & Medical Complete (Alumni)
55Nursing & Allied Health Database (Alumni Edition)
56ProQuest Newsstand Professional
57ProQuest Biological Science Collection
58Consumer Health Database
59Health & Medical Collection (Alumni Edition)
60Healthcare Administration Database
61Medical Database
62Psychology Database
63Research Library
64Science Database
65Algology Mycology and Protozoology Abstracts (Microbiology C)
66Biological Science Database
67Research Library (Corporate)
68Nursing & Allied Health Premium
69ProQuest One Academic Eastern Edition
70ProQuest One Academic
71ProQuest One Academic UKI Edition
72ProQuest Central Basic
73SIRS Editorial
jtitleThe Lancet (British edition)
delivery
delcategoryRemote Search Resource
fulltextfulltext
addata
auBeral, Valerie
aucorpMillion Women Study Collaborators
formatjournal
genrearticle
ristypeJOUR
atitleBreast cancer and hormone-replacement therapy in the Million Women Study
jtitleThe Lancet (British edition)
addtitleLancet
date2003-08-09
risdate2003
volume362
issue9382
spage419
epage427
pages419-427
issn0140-6736
eissn1474-547X
codenLANCAO
abstract
copEngland
pubElsevier Ltd
pmid12927427
doi10.1016/S0140-6736(03)14065-2
oafree_for_read